WISDOM: A Grid-Enabled Drug Discovery Initiative against Malaria - Grid Computing: Infrastructure, Service, and Applications - page 374

References
1. The Innovative Medicines Initiative (IMI) Strategic Research Agenda.
Creating Biomedical R&D Leadership for Europe to Benei t Patients and
Society, February 2008. Available at http://www.imi.europa.eu/docs/
imi-gb-006v2-15022008-research-agenda_en.pdf.
2. Lyne, P.D. Structure-based virtual screening: An overview. Drug Discovery
Today 7, 2002, 1047-1055.
3. Congreve, M., Murray, C.W., and Blundell, T.L. Structural biology and drug
discovery. Drug Discovery Today 10, 2005, 895-907.
4. Ghosh, S., Nie, A., An, J., and Huang, Z. Structure-based virtual screening of
chemical libraries for drug discovery. Current Opinion in Chemical Biology 10,
2006, 194-202.
5. Chien, A., Foster, I., and Goddette, D. Grid technologies empowering drug
discovery. Drug Discovery Today 7, 2002, 176-180.
6. PRISM forum. Available at: http://www.prismforum.org.
7. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G. Bhat, T.N., Weissig, H.,
Shindyalov, I.N., and Bourne, P.E. The Protein Data Bank. Nucleic Acids
Research 28, 2000, 235-242.
8. Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R. K.
and Olson, A.J. Automated docking using a Lamarckian genetic algorithm
and empirical binding free energy function. Journal of Computational Chemistry
19, 1998, 1639-1662.
9. Rarey, M., Kramer, B., Lengauer, T., and Klebe, G. Predicting receptor-ligand
interactions by an incremental construction algorithm. Journal of Molecular
Biology 261, 1996, 470-489.
10. Irwin, J.J. and Shoichet, B.K. ZINC—a free database of commercially avail-
able compounds for virtual screening. Journal of Chemical Information and
Modeling 45 (1), 2005, 177-182.
11. Jacq, N. et al. Grid-enabled virtual screening against malaria, Journal of Grid
Computing , 6 (1), 29-43, 2008.
12. Silva, A.M., et al. Structure and inhibition of plasmepsin II, A haemoglobin
degrading enzyme from Plasmodium falciparum. Proceedings of the National
Academy of Sciences USA 93, 1996, 10034-10039.
13. Lamb, M.L. and Jorgensen, W.L. Computational approaches to molecular
recognition. Current Opinion in Chemical Biology 1, 1997, 449.
14. Case, D.A. et al. The Amber biomolecular simulation programs. Journal of
Computational Chemistry 26, 2005, 1668-1688.
15. Ferrari, A.M., Degiesposti, G., Sgobba, M., and Rastelli, G. Validation of an
automated procedure for the prediction of relative free energies of binding
on a set of aldose reductase inhibitors. Bioorganic and Medicinal Chemistry 15,
2007, 7865-7877.
16. Luker, K.E., Francis, S.E., Gluzman, I.Y., and Goldberg, D.E. Kinetic analysis
of plasmepsin I and II aspartic protease of the Plasmodium falciparum diges-
tive vacuole, Molecular and Biochemical Parasitology 79, 1996, 71-78.
17. Matayoshi, E.D., Wang, G.T., Krafft, G.A., and Erickson, J. Novel l uorogenic
substrates for assaying retroviral proteases by resonance energy transfer.
Science 247, 1990, 954-958.